Applied Therapeutics, Inc. has announced that it will present full 12-month clinical data, along with new topline data from 18 and 24 months from the INSPIRE Phase 3 trial of its drug govorestat for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback